Veterinary Medicines

Ypozane 7.5 mg - Tablet

Authorised
  • Osateronacetat
Download as PDF

Product identification

Medicine name:
Ypozane 7.5 mg - Tablet
Active substance:
  • Osateronacetat
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Osateronacetat
    7.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG04CX90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Blister (Alu/Alu), Package_size:7 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac S.A.
Marketing authorisation issued:
Manufacturing sites for batch release:
  • VIRBAC
Authorisation country:
This information is not available for this product.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

Published:
Maltese (PDF)
Download

Combined File of all Documents

Published:
Portuguese (PDF)
Download

Combined File of all Documents

Published:
Slovak (PDF)
Download

Combined File of all Documents

Published:
Icelandic (PDF)
Download

Combined File of all Documents

Published:
Dutch (PDF)
Download

Combined File of all Documents

Published:
Italian (PDF)
Download

Combined File of all Documents

Published:
Polish (PDF)
Download

Combined File of all Documents

Published:
Norwegian (PDF)
Download

Combined File of all Documents

Published:
Romanian (PDF)
Download

Combined File of all Documents

Published:
Lithuanian (PDF)
Download

Combined File of all Documents

Published:
Latvian (PDF)
Download

Combined File of all Documents

Published:
Swedish (PDF)
Download

Combined File of all Documents

Published:
Bulgarian (PDF)
Download

Combined File of all Documents

Published:
French (PDF)
Download

Combined File of all Documents

Published:
Spanish (PDF)
Download

Combined File of all Documents

Published:
Hungarian (PDF)
Download

Combined File of all Documents

Published:
Finnish (PDF)
Download

Combined File of all Documents

Published:
Greek (PDF)
Download

Combined File of all Documents

Published:
English (PDF)
Download

Combined File of all Documents

Published:
Danish (PDF)
Download

Combined File of all Documents

Published:
Slovenian (PDF)
Download

Combined File of all Documents

Published:
Czech (PDF)
Download

Combined File of all Documents

Published:
Croatian (PDF)
Download

Combined File of all Documents

Published:
Estonian (PDF)
Download

Combined File of all Documents

Published:
German (PDF)
Download

ema-puar-ypozane-v-112-par-en.pdf

Published:
English (PDF)
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."